# Survey on the Pharmacy Follow-up of Alli Purchasers

> **NCT01387243** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 80 (actual)

## Conditions studied

- Overweight

## Interventions

- **DRUG:** Orlistat

## Key facts

- **NCT ID:** NCT01387243
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2012-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01387243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01387243, "Survey on the Pharmacy Follow-up of Alli Purchasers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01387243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*